Care cascade for patients with opioid use disorder and serious injection related infections.

Toxicology communications Pub Date : 2021-01-01 Epub Date: 2021-02-10 DOI:10.1080/24734306.2020.1869899
Anand Upadhyaya, Laura R Marks, Evan S Schwarz, Stephen Y Liang, Michael J Durkin, David B Liss
{"title":"Care cascade for patients with opioid use disorder and serious injection related infections.","authors":"Anand Upadhyaya,&nbsp;Laura R Marks,&nbsp;Evan S Schwarz,&nbsp;Stephen Y Liang,&nbsp;Michael J Durkin,&nbsp;David B Liss","doi":"10.1080/24734306.2020.1869899","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To define the care cascade for patients with serious injection drug use related infections (SIRI) in a tertiary hospital system and compare outcomes of those who did and did not participate in an opioid use disorder (OUD) treatment referral program.</p><p><strong>Methods: </strong>The medical records of patients admitted with both OUD and SIRI including endocarditis, osteomyelitis, septic arthritis, epidural abscess, thrombophlebitis, myositis, bacteremia, and fungemia from 2016-2019 were retrospectively reviewed. Patient demographics, clinical covariates, 90-day readmission rates, and outcomes data were collected. We compared data from those who were successfully referred to outpatient care through Engaging Patients in Care Coordination (EPICC), a peer recovery specialist-run OUD treatment referral program, to those who did not receive outpatient referral.</p><p><strong>Results: </strong>During the study period 334 persons who inject opioids were admitted with SIRI. Fourteen admitted patients died and were excluded from the analysis. The all-cause readmission rate was lower among patients referred to the EPICC program (18/76 [23.7%]) compared to those not referred to EPICC (100/244 [41.0%]) (OR 0.44; 95% CI 0.25 - 0.80).</p><p><strong>Conclusion: </strong>An OUD care cascade evaluation for patients with SIRI demonstrated that referral to peer recovery services with outpatient OUD treatment was associated with reduced 90-day readmission rate.</p>","PeriodicalId":23139,"journal":{"name":"Toxicology communications","volume":"5 1","pages":"6-10"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/24734306.2020.1869899","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Toxicology communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/24734306.2020.1869899","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/2/10 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Objectives: To define the care cascade for patients with serious injection drug use related infections (SIRI) in a tertiary hospital system and compare outcomes of those who did and did not participate in an opioid use disorder (OUD) treatment referral program.

Methods: The medical records of patients admitted with both OUD and SIRI including endocarditis, osteomyelitis, septic arthritis, epidural abscess, thrombophlebitis, myositis, bacteremia, and fungemia from 2016-2019 were retrospectively reviewed. Patient demographics, clinical covariates, 90-day readmission rates, and outcomes data were collected. We compared data from those who were successfully referred to outpatient care through Engaging Patients in Care Coordination (EPICC), a peer recovery specialist-run OUD treatment referral program, to those who did not receive outpatient referral.

Results: During the study period 334 persons who inject opioids were admitted with SIRI. Fourteen admitted patients died and were excluded from the analysis. The all-cause readmission rate was lower among patients referred to the EPICC program (18/76 [23.7%]) compared to those not referred to EPICC (100/244 [41.0%]) (OR 0.44; 95% CI 0.25 - 0.80).

Conclusion: An OUD care cascade evaluation for patients with SIRI demonstrated that referral to peer recovery services with outpatient OUD treatment was associated with reduced 90-day readmission rate.

阿片类药物使用障碍和严重注射相关感染患者的护理级联。
目的:定义三级医院系统中严重注射药物使用相关感染(SIRI)患者的护理级联,并比较参加和未参加阿片类药物使用障碍(OUD)治疗转诊计划的患者的结果。方法:回顾性分析2016-2019年收治的心内膜炎、骨髓炎、脓毒性关节炎、硬膜外脓肿、血栓性静脉炎、肌炎、菌血症和真菌血症患者的病历。收集患者人口统计学、临床协变量、90天再入院率和结局数据。我们比较了通过参与患者护理协调(EPICC)(同伴康复专家运行的OUD治疗转诊项目)成功转诊到门诊的患者和没有转诊到门诊的患者的数据。结果:在研究期间,334名注射阿片类药物的人接受了SIRI。14例入院患者死亡,并被排除在分析之外。接受EPICC治疗的患者的全因再入院率(18/76[23.7%])低于未接受EPICC治疗的患者(100/244 [41.0%])(OR 0.44;95% ci 0.25 - 0.80)。结论:一项针对SIRI患者的OUD护理级联评估表明,转诊到同行康复服务机构接受门诊OUD治疗与降低90天再入院率相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信